glp 1 drug zepbound Eli Lilly's Leads to Greater Weight Loss vs. Novo Nordisk in Head-to-Head Test Weight-Loss Drug Zepbound Is Being

2022 Feb 25;32:121-129

Your clinician will manage titrationslowly adjusting your medication to find the right doseand provide practical strategies to prevent or manage side effects

Exclusion criteria included a history of self-reported eating disorders (eg, anorexia nervosa and bulimia nervosa), pregnancy or active attempts to conceive, known allergies or hypersensitivity to any components of the prescribed medications, and severe medical conditions such as a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, significant hepatic impairment, renal impairment requiring dialysis, uncontrolled cardiovascular diseases, or severe gastrointestinal disorders (eg, gastroparesis and pancreatitis)

Increased competition typically drives innovation and can pressure prices down, but effects depend on market dynamics and payer responses

Weve seen similar shifts in other industries

Work with your healthcare provider to find an eating plan that works best for you and your individual needs